Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification ; volume:83 ; number:15 ; day:20 ; month:9 ; year:2023 ; pages:1387-1408 ; date:10.2023
Drugs ; 83, Heft 15 (20.9.2023), 1387-1408, 10.2023
- Creator
-
Cummings, Jeffrey L.
Osse, Amanda M. Leisgang
Kinney, Jefferson W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-023-01938-w
- URN
-
urn:nbn:de:101:1-2024010808542675793534
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cummings, Jeffrey L.
- Osse, Amanda M. Leisgang
- Kinney, Jefferson W.
- SpringerLink (Online service)
Other Objects (12)
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
The Alzheimer’s disease drug development landscape
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Alzheimer's disease
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
Non-drug Therapies for Alzheimer’s Disease: A Review
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
The Alzheimer’s disease drug development landscape
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Alzheimer's disease
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
Non-drug Therapies for Alzheimer’s Disease: A Review
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
The Alzheimer’s disease drug development landscape
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Alzheimer's disease
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets